Managing Genitourinary Syndrome of Menopause in Complex Patients

Genitourinary Syndrome of Menopause (GSM) affects millions, yet managing it in patients with complex medical histories remains a major clinical challenge. Understanding how to balance symptom relief with systemic safety is essential for modern healthcare providers. This text-only course guides you through the foundational pathophysiology of GSM, risk assessment frameworks, and evidence-based treatment pathways. You will gain the confidence to personalize therapies, evaluate hormonal and non-hormonal options, and make safe clinical decisions for high-risk patients. What you'll learn: - Understand the pathophysiological mechanisms of genitourinary syndrome of menopause and its impact on tissues. - Evaluate the safety profiles of hormonal replacement therapies, specifically focusing on patients with thrombophilia or breast cancer history. - Analyze the indications, contraindications, and clinical evidence for local hormonal therapies and implants. - Explore modern non-hormonal alternatives, including moisturizers, lubricants, and emerging non-pharmacological therapies. - Apply risk-assessment models to co-create personalized treatment plans through shared clinical decision-making. The program begins with core physiological definitions before moving into clinical assessment strategies, hormone safety data, and practical case-based scenarios for complex patient profiles. It is designed for healthcare professionals, medical students, and clinicians looking to build a foundational understanding of GSM management, with no advanced prior specialization required. Expand your clinical toolkit and deliver safer, personalized care to your patients today.